Persons enrolled in Medical Assistance (Medicaid) for a given month. Includes Temporary Assistance for Needy Families (TANF), General Assistance (GA), Disabled, & Waiver categories.

This dataset contains the count of individuals with Medical Assistance coverage (MA) receiving any form of MAT (Medication-Assisted treatment) by case county. The counts cover calendar years 2015 - 2018. If a count field is null, then the count is suppressed due to low numbers. If the county is null, then the county is unknown.

This dataset contains the total counts of PA Department of Human Services (DHS) Medical Assistance (MA) individuals diagnosed with Opioid Use Disorder (OUD) or OUD Poisoning. Also included are individuals receiving MAT (Medication assisted treatment - the use of medications in combination with counseling and behavioral therapies for the treatment of substance use disorders.) NOT diagnosed in the same period. Limited to the Newly Eligible (Under the Medical Assistance Expansion Program. Find more information here: http://www.dhs.pa.gov/cs/groups/webcontent/documents/document/c_257436.pdf) segment of DHS population. Internally defined as DHS Category of Assistance = MG (Modified Adjusted Gross Income - MAGI) MG and Program Status = 91 (Newly Eligible). Counts are reported by Pennsylvania case county and covers calendar years 2015 -2018.

The county aggregate number of individuals on Medical Assistance (MA, Medicaid) who have filled a Naloxone Prescription. This includes all individuals on Medicaid. Naloxone is an opioid antagonist. It acts on the CNS to block the effects of narcotics, especially the "high'' feeling that makes you want to use them. It will not produce any narcotic-like effects or cause mental or physical dependence. Numbers are for the Calendar Year and updated with as current as possible until the next data refresh.

This dataset summarizes the number of live births in 2016 or 2017 and indicates how many of those neonates or newborns on Medical Assistance (MA) were diagnosed in their first 90 days of life with Neonatal Abstinence Syndrome (NAS) (withdrawal symptoms or otherwise affected from maternal use of drugs of addiction).